Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral Brønsted acid catalysis method for unnatural serine. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN110218234A reveals safer Promestriene synthesis. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable solid acid catalysis.
Novel heteropolyacid-catalyzed route for Vitamin E intermediates offering high yield, environmental safety, and scalable industrial production capabilities for global supply chains.
Patent CN103224484A details a mild bismuth-catalyzed route for statin intermediates, offering significant cost reduction and scalable manufacturing capabilities for global supply chains.
Novel Bronsted acid-catalyzed route for spiro-oxindoles using 2,5-dimethylfuran. High yield, metal-free, scalable pharmaceutical intermediate manufacturing.
Patent CN112390815B details a high-yield d-biotin process. Achieve >99% purity and eliminate phosgene risks for reliable vitamin manufacturing.
Patent CN115368218B reveals a zinc-catalyzed route for 4-diarylmethyl phenols. Achieves high selectivity and yield, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel AlCl3-catalyzed cyclization route for fungicide intermediates. Offers simplified purification and scalable production for agricultural chemical manufacturers.
Novel electrophilic substitution route for 3-hydroxymethyl-4-hydroxymandelic acid. Reduces steps, lowers cost, ensures high purity for asthma medication supply chains.
Novel selenium-mediated cyclization for 2-benzoxazepines. High yield, mild conditions. Ideal for CNS drug intermediates. Cost-effective manufacturing solution.
Patent CN112299962A reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate production, offering significant cost reduction and equipment longevity.
Advanced patent CN104961675A enables safer isavuconazole intermediate production. Discover cost-effective, scalable pharmaceutical intermediate manufacturing solutions.
Patent CN1646452A details a safer phosphitylation method using hindered amine activators, offering cost reduction and scalability for oligonucleotide manufacturing.
Patent CN101100428A details a green boric acid-catalyzed route for high-purity chiral diethyl tartrate, offering cost reduction and zero-discharge manufacturing for pharma intermediates.
Patent CN116444345B reveals green ionic liquid method for fluorenyl diol. High yield, recyclable catalyst ensures supply chain stability and cost efficiency.
Novel patent CN114315608B enables cost-effective tri(4-ethynylphenyl)amine production without palladium, ensuring supply chain stability for optoelectronic manufacturers.
Novel silica-supported catalytic route for benzothiazole derivatives ensures high purity and simplified post-treatment for reliable pharmaceutical intermediate supply chains.
Novel Friedel-Crafts method for high-purity pharmaceutical intermediates. Eliminates hydrolysis, reduces cost, ensures scalable supply chain continuity.
Patent CN111253406A details a green synthesis route for dihydrobenzo imidazo pyrimidine derivatives using magnetic graphene, offering high purity and recyclable catalysts for reliable pharmaceutical intermediate supply.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.